Novel mitochondrial-related risk model as prognostic biomarker for stomach adenocarcinoma
March 28, 2023
Researchers from Shanxi Medical University and affiliated organizations presented data from a study that aimed to analyze the expression and prognostic value of mitochondrial-related genes in patients with stomach adenocarcinoma (STAD).